This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Apr 10;375(9722):1225.

doi: 10.1016/S0140-6736(10)60523-5.

Strengthening the credibility of clinical research

No authors listed

PMID: 20382309
DOI: 10.1016/S0140-6736(10)60523-5

Editorial

Strengthening the credibility of clinical research

No authors listed. Lancet. 2010.

. 2010 Apr 10;375(9722):1225.

doi: 10.1016/S0140-6736(10)60523-5.

PMID: 20382309
DOI: 10.1016/S0140-6736(10)60523-5

No abstract available

PubMed Disclaimer

Comment in

Strengthening the credibility of clinical research.
Deangelis CD, Fontanarosa PB. Deangelis CD, et al. Lancet. 2010 Jul 24;376(9737):234. doi: 10.1016/S0140-6736(10)61145-2. Lancet. 2010. PMID: 20656125 No abstract available.

Similar articles

Faster publication isn't always better.
Fuster V, Farkouh ME. Fuster V, et al. Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):345. doi: 10.1038/ncpcardio0942. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17589426 No abstract available.
GSK is accused of trying to suppress editorial on rosiglitazone.
Tanne JH. Tanne JH. BMJ. 2010 May 19;340:c2654. doi: 10.1136/bmj.c2654. BMJ. 2010. PMID: 20484354 No abstract available.
Rosiglitazone, marketing, and medical science.
Moynihan R. Moynihan R. BMJ. 2010 Apr 7;340:c1848. doi: 10.1136/bmj.c1848. BMJ. 2010. PMID: 20375091 No abstract available.
Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue.
Faillie JL, Hillaire-Buys D. Faillie JL, et al. Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):212-4. doi: 10.1002/pds.3925. Epub 2015 Nov 30. Pharmacoepidemiol Drug Saf. 2016. PMID: 26617411 Review. No abstract available.
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
Misbin RI. Misbin RI. Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908. Diabetes Care. 2007. PMID: 18042753 Review. No abstract available.

See all similar articles

Cited by

Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO search portal.
Reveiz L, Chan AW, Krleza-Jerić K, Granados CE, Pinart M, Etxeandia I, Rada D, Martinez M, Bonfill X, Cardona AF. Reveiz L, et al. PLoS One. 2010 Aug 31;5(8):e12484. doi: 10.1371/journal.pone.0012484. PLoS One. 2010. PMID: 20824212 Free PMC article.
Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles.
Blümle A, Meerpohl JJ, Rücker G, Antes G, Schumacher M, von Elm E. Blümle A, et al. BMJ. 2011 Apr 5;342:d1828. doi: 10.1136/bmj.d1828. BMJ. 2011. PMID: 21467104 Free PMC article.
Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers.
Calvert M, Kyte D, Duffy H, Gheorghe A, Mercieca-Bebber R, Ives J, Draper H, Brundage M, Blazeby J, King M. Calvert M, et al. PLoS One. 2014 Oct 15;9(10):e110216. doi: 10.1371/journal.pone.0110216. eCollection 2014. PLoS One. 2014. PMID: 25333995 Free PMC article.
SPIRIT 2025 statement: updated guideline for protocols of randomised trials.
Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari N, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne DR, Farmer AJ, Fergusson DA, Golub RM, Goodman SN, Hoffmann TC, Ioannidis JPA, Kahan BC, Knowles RL, Lamb SE, Lewis S, Loder E, Offringa M, Ravaud P, Richards DP, Rockhold FW, Schriger DL, Siegfried NL, Staniszewska S, Taylor RS, Thabane L, Torgerson DJ, Vohra S, White IR, Hróbjartsson A. Chan AW, et al. BMJ. 2025 Apr 28;389:e081477. doi: 10.1136/bmj-2024-081477. BMJ. 2025. PMID: 40294953 Free PMC article.
Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
Lundh A, Krogsbøll LT, Gøtzsche PC. Lundh A, et al. Trials. 2012 Aug 24;13:146. doi: 10.1186/1745-6215-13-146. Trials. 2012. PMID: 22920226 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information